Home>Topics>Stocks>GlaxoSmithKline PLC

GlaxoSmithKline PLC GSK

  1. All
  2. Commentary
  3. Headlines
    1. UPDATE 1-J&J, Glaxo settle U.S. lawsuit over allergy ads

      Headlines

      Mon, 30 Mar 2015

      NEW YORK, March 30 (Reuters) - GlaxoSmithKline Plc has agreed to settle a lawsuit by Johnson & Johnson accusing it of using false advertising at the start of the U.S. allergy season to grab market share.

    2. J&J, Glaxo settle U.S. lawsuit over allergy ads

      Headlines

      Mon, 30 Mar 2015

      NEW YORK, March 30 (Reuters) - GlaxoSmithKline Plc has agreed to settle a lawsuit by Johnson & Johnson accusing it of using false advertising at the start of the U.S. allergy season to grab market share.

    3. UPDATE 1-Two experimental Ebola vaccines pass safety test in African trial

      Headlines

      Thu, 26 Mar 2015

      NEW YORK, March 26 (Reuters) - Two experimental Ebola vaccines, one from GlaxoSmithKline PLC and the other from biotech start-up NewLink Genetics Corp, "appear to be safe" part way through a clinical trial being conducted

    4. Two experimental Ebola vaccines pass safety test in African trial

      Headlines

      Thu, 26 Mar 2015

      NEW YORK, March 26 (Reuters) - Two experimental Ebola vaccines, one from GlaxoSmithKline PLC and the other from biotech start-up NewLink Genetics Corp, "appear to be safe" part way through a clinical trial being conducted

    5. UPDATE 2-FDA panel backs Glaxo asthma drug for adults, not adolescents

      Headlines

      Thu, 19 Mar 2015

      March 19 (Reuters) - GlaxoSmithKline Plc 's drug to treat chronic breathing problems is safe and effective enough for adults with asthma to use but not adolescents, an advisory panel to the U.S. Food and Drug Administration concluded on Thursday.

    6. FDA panel backs Glaxo asthma drug for adults, not adolescents

      Headlines

      Thu, 19 Mar 2015

      March 19 (Reuters) - GlaxoSmithKline Plc 's drug to treat chronic breathing problems is safe and effective enough to be approved in adults with asthma but not adolescents, an advisory panel to the U.S. Food and Drug Administration concluded on Thursday.

    7. UPDATE 2-FDA staff finds no new safety problems with Glaxo's asthma drug

      Headlines

      Tue, 17 Mar 2015

      March 17 (Reuters) - GlaxoSmithKline Plc 's respiratory treatment for chronic breathing problems did not show any new safety problems while being tested to treat asthma, a preliminary review by U.S. Food and Drug Administration staff found.

    8. FDA staff finds no new safety problems with Glaxo's asthma drug

      Headlines

      Tue, 17 Mar 2015

      March 17 (Reuters) - GlaxoSmithKline Plc 's respiratory treatment for chronic breathing problems did not show any new safety problems in treating asthma, a preliminary review by U.S. Food and Drug...

    9. Johnson & Johnson sues Glaxo over allergy ads as spring nears

      Headlines

      Thu, 12 Mar 2015

      NEW YORK, March 12 (Reuters) - Johnson & Johnson sued rival drugmaker GlaxoSmithKline PLC on Thursday, alleging that Glaxo is trying to unlawfully grab market share with false advertising at the...

    10. ChemoCentryx says partner GSK returns rights to bowel disease drug

      Headlines

      Wed, 18 Sep 2013

      Sept 18 (Reuters) - ChemoCentryx Inc said partner GlaxoSmithKline Plc returned the rights to its inflammatory bowel disease drug, the company's lead product candidate.

    « Prev123Next »
    Content Partners